U.K. Approves First Oral Weight Drug | Europe News

The U.K. just approved Eli Lilly’s new weight-loss pill, Foundayo — the first oral GLP-1 drug ever approved in Europe for weight and type 2 diabetes, shaking up a market dominated by injections. With celebrity buzz and growing demand for non-invasive options, this pill could spark wider adoption across the continent. But pricing tensions remain, as the U.K. is the only EU country to agree to a higher U.S.-set price — and whether the NHS will cover it? That’s still up in the air later this year. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d02c6d69b8c79249